The effect of the GLP-1 analogue Liraglutide on intermittent hypoxia-induced systemic insulin resistance in vivo
A. King (Dublin 4, Ireland), C. Arnaud (Grenoble, France), G. Vial (Grenoble, France), E. Billoir (Grenoble, France), B. Ozcan (Grenoble, France), E. Belaidi (Grenoble, France), C. O'Donnell (Dublin , Ireland), S. Ryan (Dublin , Ireland)
Source: International Congress 2022 – Translational research in sleep apnoea: from the molecule and the signal to the clinic
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. King (Dublin 4, Ireland), C. Arnaud (Grenoble, France), G. Vial (Grenoble, France), E. Billoir (Grenoble, France), B. Ozcan (Grenoble, France), E. Belaidi (Grenoble, France), C. O'Donnell (Dublin , Ireland), S. Ryan (Dublin , Ireland). The effect of the GLP-1 analogue Liraglutide on intermittent hypoxia-induced systemic insulin resistance in vivo. 4385
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|